Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
JODI data: Saudi domestic refineries' crude throughput fell 20,000 bpd in July to 2.4778mlnbpd.
2026-09-22
JODI data: Saudi domestic refineries' crude throughput fell 20,000 bpd in July to 2.4778mlnbpd.
Back
Other News
2026-09-22
The head of the Atomic Energy Organization of Iran stated that despite attempts to obstruct Iran's participation in the International Atomic Energy Agency (IAEA) General Assembly, Iran was ultimately elected as a member of the IAEA General Assembly C
The head of the Atomic Energy Organization of Iran stated that despite attempts to obstruct Iran's participation in the International Atomic Energy Agency (IAEA) General Assembly, Iran was ultimately elected as a member of the IAEA General Assembly Committee, despite attempts by the United States to block it.
2026-09-23
Novo Nordisk said it is open to upgrading its U.S. listing — potentially replacing its American depositary receipts with a direct New York listing — as the Danish maker of weight‑loss drugs seeks greater U.S. visibility. Asked whether the company wou
Novo Nordisk said it is open to upgrading its U.S. listing — potentially replacing its American depositary receipts with a direct New York listing — as the Danish maker of weight‑loss drugs seeks greater U.S. visibility. Asked whether the company would consider listing shares directly on the NYSE instead of ADRs, the CEO said he saw advantages and would not rule it out but added the company is not currently studying the option. He noted rival AstraZeneca made a similar move earlier this year.
Chat with us
, powered by
LiveChat